Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

'TRANSLATE: A randomised controlled trial of TRANSrectal biopsy versus Local Anaesthetic Transperineal biopsy Evaluation of clinically significant prostate cancer'

Biography

Richard Bryant

 

Richard Bryant is a Cancer Research UK Clinician Scientist Fellow (joint with the Royal College of Surgeons of England), which enables him to continue to combine his care of prostate cancer patients with a wide and growing prostate cancer research portfolio, covering the breadth of basic science, translational, and clinical research, at the Nuffield Department of Surgical Sciences.

He has been the Lead Clinician for the VANCE (VAcciNation in prostate CancEr) Clinical trial in Oxford since 2015, and in 2017 Richard commenced his current position as Honorary Consultant Urologist at the Churchill Hospital in Oxford.

He also delivers undergraduate teaching in surgery and urology to clinical medical students.

Richard undertook his undergraduate medical training at the University of Sheffield, where he completed an intercalated BMedSci degree in pathology in 1995, and qualified in 1998. After completing Basic Surgical Training in South Yorkshire in 2003, he was awarded a Medical Research Council Fellowship (2004-2007) and undertook a PhD researching molecular mechanisms of prostate cancer progression. I then undertook higher surgical training in Urology in both Sheffield and Oxford, whilst in parallel continuing to pursue his prostate cancer research interests, leading to numerous scientific publications in this field under the mentorship of Professor Freddie Hamdy. In 2015, Richard was appointed Locum Consultant Urologist in Oxford and continued to combine clinical practice, specialising in the diagnosis and management of prostate cancer, with prostate cancer research. In 2017 he was appointed Honorary Consultant Urologist in Oxford.

The Chief Medical Officer has confirmed that attendance at the Surgical Grand Rounds can count toward internal CPD, with 1 point awarded per hour. Please note that in-person attendance is required, and you will need to sign the attendance register.

All members of the University and NHS clinical staff are welcome.

Please email Louise King if you would like to attend online.